Skip to main content
Premium Trial:

Request an Annual Quote

Foundation Medicine, Bristol Myers Squibb Expand CDx Partnership to Investigational Cancer Drug

NEW YORK – Foundation Medicine said Tuesday that it has expanded an ongoing collaboration with Bristol Myers Squibb to include companion diagnostic development for the pharma firm's investigational tyrosine kinase inhibitor repotrectinib.

Repotrectinib is an orally administered tyrosine kinase inhibitor that is being evaluated in an ongoing registrational Phase I/II trial called TRIDENT-1 for patients with TKI-naive or TKI-pretreated ROS1+ advanced non-small cell lung cancer, as well as those with NTRK+ advanced solid tumors.

BMS has been using the FoundationOne CDx tissue-based genomic profiling assay to recruit these biomarker-defined patients. If the drug is ultimately approved by the US Food and Drug Administration, Foundation's CDx assay could also be approved as a companion diagnostic.

Jason Adams, Foundation's VP of biopharma enterprise partnerships, said in a statement that the move furthers the company's commitment "to deliver more treatment options to patients who need them."

FoundationOne CDx is already FDA approved for genomic profiling in advanced cancer, and as a companion diagnostic for a number of FDA-approved drugs including those targeting alterations in EGFR, ALK, BRAF, and MET.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.